How much cash does Olema Pharmaceuticals, Inc. generate?

Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.

What is Olema Pharmaceuticals, Inc.'s free cash flow?

After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.

Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?

Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Olema Pharmaceuticals, Inc. OLMA Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Net income	-$162.45M-25.5%	-$129.47M-34.0%	-$96.66M+7.8%	-$104.79M-47.4%
Depreciation and amortization	$490K+24.7%	$393K+4.2%	$377K+5.6%	$357K+119%
Stock-based compensation	$17.59M-22.1%	$22.58M+30.9%	$17.26M-8.4%	$18.83M+18.3%
Change in accounts payable	——	——	$2.32M—	——
Change in other assets	$5.77M+1,244%	$429K—	——	$1.96M+4,798%
Change in other liabilities	$10.98M-1.9%	$11.2M+280%	$2.95M-58.0%	$7.02M—
Non-cash operating lease expense	$1.18M+2.3%	$1.15M-11.3%	$1.3M-0.3%	$1.3M+6.3%
Change in operating lease liabilities	-$1.24M-7.1%	-$1.16M+5.6%	-$1.23M+3.4%	-$1.27M-28.9%
Debt issuance costs and discount amortization	-$6.29M+23.0%	-$8.18M—	——	——
Net cash from operating activities	-$146.72M-40.6%	-$104.35M-24.6%	-$83.73M-2.0%	-$82.07M-61.9%
Net cash from investing activities	——	-$93.53M-1,828%	-$4.85M-105%	$91.48M—
Proceeds from issuance of common stock	$8.39M+402%	$1.67M-36.4%	$2.63M+1,701%	$146K—
Taxes paid for net share settlement	——	——	——	——
Net cash from financing activities	$211.3M-21.4%	$268.82M+101%	$133.42M+27,928%	$476K—
Net increase (decrease) in cash	——	$70.94M—	——	——
Amortization Of Debt Discount Premium	-$6.29M+23.0%	-$8.18M—	——	——
Operating lease liabilities	-$1.24M-7.1%	-$1.16M+5.6%	-$1.23M+3.4%	-$1.27M-28.9%
Current liabilities	$10.98M-1.9%	$11.2M+280%	$2.95M-58.0%	$7.02M—
Increase Decrease In Other Non Current Assets And Long Term Deposits	$6.15M+108%	$2.96M—	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$5.77M+1,244%	$429K—	——	$1.96M+4,798%
Investment Income Nonoperating	——	$8.18M+48.0%	$5.52M—	——
Operating lease right-of-use asset amortization	$1.18M+2.3%	$1.15M-11.3%	$1.3M-0.3%	$1.3M+6.3%
Payment For Issuance Costs For Shares Issued Under Private Placement	——	——	——	——
Payment For Issuance Costs For Shares Issued Under Follow On Offering	——	——	——	——
Proceeds From Issuance Of Shares Under At The Market Offering	——	——	——	——
Proceeds From Issuance Of Shares Upon Follow On Public Offering	$205.39M—	——	——	——
Increase Decrease In Operating Lease Liability	-$1.24M-7.1%	-$1.16M+5.6%	-$1.23M+3.4%	-$1.27M-28.9%
Implementation Cost Included In Other Current Liabilities	-$95K+71.8%	-$337K—	——	——
Research And Development Project Deposit Applied Against Study Invoices	$177K-76.3%	$748K—	——	——
Unpaid Issuance Costs Related To Follow On Offering And Two Thousand Twenty Four Private Placement	$578K-91.1%	$6.5M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Olema Pharmaceuticals, Inc. generate?: Olema Pharmaceuticals, Inc. (OLMA) generated -$148.7M in operating cash flow over the trailing twelve months.
What is Olema Pharmaceuticals, Inc.'s free cash flow?: After $332.0K of capital expenditures, Olema Pharmaceuticals, Inc.'s free cash flow was -$115.4M over the trailing twelve months, down 30.9% year over year.
Where does Olema Pharmaceuticals, Inc.'s cash flow data come from?: Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.